-
Fox Medical Team reports on upcoming Cervical Phase of Neuralstem’s ALS Clinical Trial
By Beth Galvin, My Fox Atlanta, November 9, 2011
View
CNN Health reports on Neuralstem’s groundbreaking ALS clinical trial moving into the cervical transplantation stage. | 11.21.11
Newsweek spotlights Neuralstem as a company to watch, includes interviews with ALS trial investigators and surgeon, and a patient. | 11.18.11
Gizmodo Science reports on the promise of Neuralstem’s first-in-class, neuroregenerative
NSI-189 small molecule drug recently FDA-approved to advance to Phase Ib trial for major depressive disorder. | 1.9.12
Newsweek spotlights Neuralstem as a company to watch, includes interviews with ALS trial investigators and surgeon, and a patient. | 11.18.11
Gizmodo Science reports on the promise of Neuralstem’s first-in-class, neuroregenerative
NSI-189 small molecule drug recently FDA-approved to advance to Phase Ib trial for major depressive disorder. | 1.9.12
